238 filings
ARS
2023 FY
CRSP
CRISPR Therapeutics AG
9 Apr 24
Annual report to shareholders
4:47pm
DEFA14A
CRSP
CRISPR Therapeutics AG
9 Apr 24
Additional proxy soliciting materials
4:43pm
DEF 14A
CRSP
CRISPR Therapeutics AG
Definitive proxy
9 Apr 24
4:42pm
PRE 14A
CRSP
CRISPR Therapeutics AG
Preliminary proxy
27 Mar 24
4:30pm
10-K
2023 FY
CRSP
CRISPR Therapeutics AG
Annual report
21 Feb 24
7:50am
8-K
pbam ptex5eahp
21 Feb 24
CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
7:45am
8-K
ecobm4w8o kw4108
13 Feb 24
Entry into a Material Definitive Agreement
5:22pm
424B5
tnuyzlwrpuxe0ps8sg3
13 Feb 24
Prospectus supplement for primary offering
8:44am
8-K
5htblgu1okf5whn6d
13 Feb 24
Other Events
6:30am
8-K
ay653g7m
16 Jan 24
Other Events
4:11pm
8-K
y2j838cyf6djqy5jn1e
19 Dec 23
Departure of Directors or Certain Officers
4:23pm
8-K
yvuk75t 8m
15 Dec 23
Other Events
8:58am
8-K
kssen
13 Dec 23
Entry into a Material Definitive Agreement
9:22am
8-K
xn8y2ikgp27wk3v
8 Dec 23
Other Events
1:16pm
8-K
jw8kn
4 Dec 23
Other Events
4:26pm
8-K
ar2xohw1 cmedox
16 Nov 23
Other Events
7:21am
8-K
2620u 4c01
6 Nov 23
CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2023 Financial Results
4:33pm
8-K
fy7ia
7 Sep 23
CRISPR Therapeutics Announces Leadership Transition
8:39am
S-8
y8b 5iqnpwiw68gf
7 Aug 23
Registration of securities for employees
4:18pm